Eagan, MN – According to filings with the U.S. Securities and Exchange Commission, Predictive Oncology is raising $9,371,971.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Bob Myers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Predictive Oncology

A multi-faceted, knowledge-driven company focused on applying artificial intelligence to develop personalized medical treatments, lab media that replicates the body and extraordinary vaccines. Predictive Oncology (NASDAQ: POAI) is focused on the use of data and artificial intelligence (AI) to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcome. The company has several tools that support its mission of bringing precision medicine to the diagnosis of cancer.

To learn more about Predictive Oncology, visit http://predictive-oncology.com/

Contact:
Bob Myers, Chief Financial Officer
651-389-4806

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved